Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr;89(4):759-79.
doi: 10.1016/j.fertnstert.2008.02.096.

Asherman syndrome--one century later

Affiliations
Free article
Review

Asherman syndrome--one century later

Dan Yu et al. Fertil Steril. 2008 Apr.
Free article

Abstract

Objective: To provide an update on the current knowledge of Asherman syndrome.

Design: Literature review.

Setting: The worldwide reports of this disease.

Patient(s): Patients with Asherman syndrome who presented with amenorrhea or hypomenorrhea, infertility, or recurrent pregnancy loss.

Intervention(s): Hysteroscopy and hysteroscopic surgery have been the gold standard of diagnosis and treatment respectively for this condition.

Main outcome measure(s): The etiology, pathology, symptomatology, diagnosis, treatment, and reproductive outcomes were analyzed.

Result(s): This syndrome occurs mainly as a result of trauma to the gravid uterine cavity, which leads to the formation of intrauterine and/or intracervical adhesions. Despite the advances in hysteroscopic surgery, the treatment of moderate to severe Asherman syndrome still presents a challenge. Furthermore, pregnancy after treatment remains high risk with complications including spontaneous abortion, preterm delivery, intrauterine growth restriction, placenta accrete or praevia, or even uterine rupture.

Conclusion(s): The management of moderate to severe disease still poses a challenge, and the prognosis of severe disease remains poor. Close antenatal surveillance and monitoring are necessary for women who conceive after treatment.

PubMed Disclaimer

MeSH terms